Bioethik und Politik

  • Robert M. Cook-Deegan


In diesem Beitrag stelle ich die Bemühungen der US-Bundesregierung dar, bei Entscheidungen über Entwicklungen in der Biologie und Medizin ethische Gesichtspunkte zu berücksichtigen. Ich werde mehrere prominente nationale Kommissionen, Programme zur Förderung angewandter Ethik durch Bundesinstitutionen und Versuche behandeln, die ethische Güterabwägung in die politische Entscheidung einzubeziehen.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Government Printing Office, Washington/DC (sofern keine eigene Angabe): — The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research (1978)Google Scholar
  2. — Ethical guidelines for the delivery of health services by DHEW (1978)Google Scholar
  3. — Institutional review boards (1978)Google Scholar
  4. — Psychosurgery (1977)Google Scholar
  5. — Research involving children (1977)Google Scholar
  6. — Research involving prisoners (1976)Google Scholar
  7. — Research involving those institutionalized as mentally infirm (1978)Google Scholar
  8. — Research on the fetus (1975)Google Scholar
  9. — Special study: Implications of advances in biomedical and behavioral research (1978). DHEW Publication No 78-0015Google Scholar
  10. President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Government Printing Office, Washington/DC alphabetisch geordnet): — Compensating for research injury (Bericht, vol. 1, Anhänge, vol. 2) (1982)Google Scholar
  11. — Deciding to Forego life-sustaining treatment (1983)Google Scholar
  12. — Defining death (1981)Google Scholar
  13. — Implementing human research regulations (1983)Google Scholar
  14. — Making health care decisions (Bericht, vol. 1, Anhänge vol. 2 und 3 (1982)Google Scholar
  15. — Protecting human subjects (1981)Google Scholar
  16. — Screening and counseling for genetic conditions (1983)Google Scholar
  17. — Securing access to health care (Bericht vol. 1, Anhänge vol. 2 und 3) (1983)Google Scholar
  18. — Splicing life (1982)Google Scholar
  19. — Summing up (1983)Google Scholar
  20. — Whistleblowing in biomedical research (1981)Google Scholar
  21. Office of Technology Assessment. U.S. Congress, Auswahl der Berichte mit ethischer Bewertung. Government Printing Office, Washington/DC (in chronologischer Reihenfolge): — Cost effectivness of medical technology (1980)Google Scholar
  22. — Strategies for medical technology assessmentGoogle Scholar
  23. — The role of genetic testing in the prevention of occupational disease (1983)Google Scholar
  24. — Human gene therapy (1984)Google Scholar
  25. — Reproductive hazards in the workplace (1985)Google Scholar
  26. — Alternatives to animal use in research, testing, and education (1986)Google Scholar
  27. — Ownership of human tissues and cells (March 1987)Google Scholar
  28. — Losing a million minds: Confronting the tragedy of Alzheimer’s disease and other dementias (April 1987)Google Scholar
  29. — Medical decision making for the demand and dying (vol. 64, suppl. 2, Milbank Quarterly, 1986)Google Scholar
  30. — Infertility, medical and social choices (May 1988)Google Scholar
  31. — New developments in biotechnology, vol. 4: US investments in biotechnology (May 1988)Google Scholar
  32. — Mapping our genes — the genom projects, how big, how fast (April 1988)Google Scholar
  33. Cardozo Law Review 6 (No 2), Winter 1984: Symposium: Commissioning morality: A critique of the President’s Commission for the study of ethical problems in medicine and biomedical and behavioral research. Mit sieben Artikeln über die ‚president’s Commission‘, von denen einer im Text erwähnt ist, nämüchGoogle Scholar
  34. Bayer R (1985) Ethics, politics, and access to health care: A critical analysis of the President’s Commission for the study of ethical problems in medicine and biomedical and behavioral research, pp 303–320Google Scholar
  35. Sonstige Literatur — keine umfassende Liste, sondern nur eine kleine Auswahl von Artikeln, die den Prozeß und die Produkte der verschiedenen Kommissionen und Organisationen kritisch darstellenGoogle Scholar
  36. Abram MB, Wolf SM (1984) Public involvement in medical ethics: A model for government action. N Engl J Med 310:627–632PubMedCrossRefGoogle Scholar
  37. Annas GJ (1979) All the President’s bioethicists. Hastings Center Rep February 1979, pp 14–15Google Scholar
  38. Annas GJ (1980) Report on the National Commission: good as gold. Medicolegal News, December 1980, pp 4–7Google Scholar
  39. Boone CK (1983) Splicing life; with scalpel and scythe. Hastings Center Rep April 1983, pp 8–10Google Scholar
  40. Jonsen AR, Yesley M (1980) Rhetoric and research ethics: An answer to Annas. Medicolegal News, December 1980, pp 8–13Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • Robert M. Cook-Deegan

There are no affiliations available

Personalised recommendations